Goodman Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Goodman Financial's GILD Position: Q4 2022 in Review
Goodman Financial sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 150,859 shares — an estimated $9.31M sold.
Goodman Financial first reported a position in GILD in Q1 2018 and held it in 19 quarters. The position peaked at $9.43M in Q4 2021. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.
- Goodman Financial reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
- Goodman Financial sold 150,859 Gilead Sciences shares in Q4 2022, an estimated $9.31M.
- Goodman Financial first reported a position in Gilead Sciences in Q1 2018 and held it in 19 quarters.
- Goodman Financial's Gilead Sciences position peaked at $9.43M in Q4 2021.
- 1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.
Based on Goodman Financial's 13F filing for Q4 2022, filed 9 Feb 2023.